Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hutchmed [China] Limited (HCM.LN)

Hutchmed [China] Limited (HCM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hutchmed [China] Limited 2 Queen's Road Central 48th Floor, Cheung Kong Center Hong Kong HKG

https://www.hutch-med.com P: 852-212-1820 F: 852-212-8177

Description:

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Key Statistics

Overview:

Market Capitalization, $K 2,646,295
Shares Outstanding, K 853,644
Annual Sales, $ 837,999 K
Annual Net Income, $ 100,780 K
Last Quarter Sales, $ 75,806 K
Last Quarter Net Income, $ -61,254 K
% of Insider Shareholders 2.77%
% of Institutional Shareholders 2.14%

Growth:

1-Year Return 30.53%
3-Year Return -19.69%
5-Year Return -22.69%
5-Year Revenue Growth 31.38%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.12
EPS Growth vs. Prev Year 76.47%
Dividend Payout Ratio 0.00%
Most Recent Split 10-1 on 05/30/19

HCM.LN Ratios

Ratio
Price/Earnings ttm 32.39
Price/Earnings forward N/A
Return-on-Equity % 15.03%
Return-on-Assets % 8.73%
Profit Margin % 12.03%
Debt/Equity 0.07
Price/Sales 4.03
Price/Book 4.54
Book Value/Share 0.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar